Eduardo Bruno Martins

2023

In 2023, Eduardo Bruno Martins earned a total compensation of $1.5M as Chief Medical Officer at Sagimet Biosciences, a 181% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$202,840
Option Awards$594,620
Salary$442,930
Stock Awards$265,127
Other$3,564
Total$1,509,081

Martins received $594.6K in option awards, accounting for 39% of the total pay in 2023.

Martins also received $202.8K in non-equity incentive plan, $442.9K in salary, $265.1K in stock awards and $3.6K in other compensation.

Rankings

In 2023, Eduardo Bruno Martins' compensation ranked 788th out of 2,978 executives tracked by ExecPay. In other words, Martins earned more than 73.5% of executives.

ClassificationRankingPercentile
All
788
out of 2,978
74th
Division
Manufacturing
460
out of 1,637
72nd
Major group
Chemicals And Allied Products
315
out of 906
65th
Industry group
Drugs
307
out of 869
65th
Industry
Pharmaceutical Preparations
205
out of 627
67th
Source: SEC filing on April 18, 2024.

Martins' colleagues

We found three more compensation records of executives who worked with Eduardo Bruno Martins at Sagimet Biosciences in 2023.

2023

David Happel

Sagimet Biosciences

Chief Executive Officer

2023

George Kemble

Sagimet Biosciences

Chief Executive Officer

2023

Dennis Hom

Sagimet Biosciences

Chief Financial Officer

News

You may also like